bOPV Bivalent Type 1+3 Vaccine: Comprehensive Protection Against Polio

SKU: S0001374
Short description

bOPV Bivalent Type 1+3 Vaccine – Comprehensive Polio Protection

The bOPV Bivalent 1+3 Vaccine offers effective protection against polio for children aged 0 to 5. Key Features:

  • Ready-to-use, multi-dose vial designed to interrupt poliovirus transmission.
  • Vaccine features both type 1 and type 3 Oral Poliomyelitis.
  • Included Vaccine Vial Monitor (VVM) safeguards vaccine potency.
  • Simple administration via two oral drops from the dispenser prevents contamination.
  • Requires storage at maximum -20°C until expiry or 2°C-8°C for up to six months.

Enable a polio-free future with the bOPV Bivalent 1+3 Vaccine.

Quantity :
  • Procurenet Team Tshim Sha Tsui
    Hong Kong Hong Kong 3 years

Fight the global health crisis of polio with the bOPV Bivalent Type 1+3 Vaccine. Developed with precision and cutting-edge techniques, this vaccine is a key player in the fight against polio. The extraordinary feature of bOPV (Bivalent Oral Polio Vaccine) is its dual protection against type 1 and type 3 poliovirus strains, the most prevalent causes of polio.

Quick Overview

  • Bi-protection against type 1 and type 3 polioviruses, providing comprehensive immunity
  • Indispensable for Supplementary Immunization Activities (SIAs), targeting children aged 0 to 5
  • 20-Dose Vial capacity ensuring greater coverage
  • Features Vaccine Vial Monitor (VVM) technology for maintaining optimal vaccine potency
  • Flexible storage options - warm chain storage is feasible without loss of efficacy

Unique Capabilities

Our bOPV Bivalent Type 1+3 Vaccine is not only a preventative measure against polio but also a transformative tool enhancing global immunization strategies. It targets and provides immunity against both type 1 and type 3 poliovirus strains, integral in polio eradication programs.

Vaccine Vial Monitor (VVM) Technology

One of the distinguishing features of bOPV Bivalent Type 1+3 Vaccine is the integration of VVM, which displays the vaccine's thermal status to ensure potency.

20-Dose Capacity

The large 20-dose capacity of each vial aids in widespread immunizations, expediting mass immunity in larger population groups.

Administration and Storage

The bOPV Bivalent Type 1+3 Vaccine is ready for immediate use, applicable through a dropper or dispenser format, ensuring swift administration. Administered orally, two drops at a time, the vaccine is non-invasive and easy to administer, which is highly beneficial during large-scale immunization activities.

Post opening, it allows for warm chain storage, meaning the vials can be effective up to four weeks if stored under specific conditions as recommended by the manufacturer, reducing wastage and ensuring maximum utilization.

The bOPV Advantage

While trivalent vaccines continue in routine vaccination programs, the bivalent vaccine plays a pivotal role in interrupting type 1 and type 3 poliovirus transmissions. Simply put, bOPV Bivalent Type 1+3 Vaccine is a valuable asset in the universal fight against polio.

All categories